Biosimilars

Health
9:45 am
Thu September 12, 2013

State Lawmakers Considering Regulations for New Biosimilar Drugs

State lawmakers are considering regulations for what some call a whole new “breed” of medicine not yet on the U.S. market.

A biosimilar medication is a drug created to mimic another medication without being biologically exact.
    
The drugs are allowed in Europe, but in the U.S., federal regulators are still drafting rules for the drugs — like which ones will be deemed “interchangeable” with other biologic medicine.

Read more